Protective vaccine for H5N1 Flu using H5 protein and a novel TLR4 agonist.
TRIA BIOSCIENCE CORP. · Department of Health and Human Services
Phase II2011$3,000,000
DESCRIPTION (provided by applicant): H5N1 is a highly pathogenic avian influenza virus that can cause severe disease and death in humans. H5N1 is spreading rapidly in bird populations world-wide and there is great conce…